ArTara Therapeutics, Inc.(TARA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TARA ArTara Therapeutics, Inc.

休市中 05-03 16:00:00 EDT

2.91

+0.02

+0.69%

盘后2.91

+0.000.00%

16:15 EDT

最高2.99	最低2.84	成交量13.44万
今开2.91	昨收2.89	日振幅5.36%
总市值5,988万	流通市值3,821万	总股本2,058万
成交额39.26万	换手率1.02%	流通股本1,313万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TARA","market":"US","secType":"STK","nameCN":"ArTara Therapeutics, Inc.","latestPrice":2.91,"timestamp":1714766400000,"preClose":2.89,"halted":0,"volume":134386,"hourTrading":{"tag":"盘后","latestPrice":2.91,"preClose":2.91,"latestTime":"16:15 EDT","volume":15500,"amount":45100.46,"timestamp":1714767336846},"delay":0,"floatShares":13131700,"shares":20578425,"eps":-3.567098,"marketStatus":"休市中","marketStatusCode":7,"change":0.02,"latestTime":"05-03 16:00:00 EDT","open":2.91,"high":2.99,"low":2.835,"amount":392561.85204,"amplitude":0.053633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.567098,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1413950400000,"adjPreClose":2.89,"preHourTrading":{"tag":"盘前","latestPrice":2.89,"preClose":2.89,"latestTime":"09:12 EDT","volume":152,"amount":439.53004,"timestamp":1714741920832},"postHourTrading":{"tag":"盘后","latestPrice":2.91,"preClose":2.91,"latestTime":"16:15 EDT","volume":15500,"amount":45100.46,"timestamp":1714767336846},"volumeRatio":0.39774469485810166},"requestUrl":"/m/hq/s/TARA","defaultTab":"news","newsList":[{"id":"2432509988","title":"Protara Therapeutics Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432509988","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432509988?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:42","pubTimestamp":1714660979,"startTime":"0","endTime":"0","summary":"   * Protara Therapeutics Inc   报告，截至1月底的季度调整后每股亏损97美分，低于去年同期的每股收益-80美分。四位分析师对该季度的平均预期是每股亏损 92 美分。华尔街预期为每股亏损 1.07 美元至-64 美分。* Protara Therapeutics Inc 报告的季度每股收益为亏损 97 美分。* 该公司当季亏损 1110 万美元。* Protara Therapeutics Inc 的股价本季度下跌了 26.9%，今年迄今为止上涨了 56.3%。华尔街对 Protara Therapeutics Inc 的 12 个月目标价中位数为 23.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431327744","title":"Protara Therapeutics Inc   预计每股亏损92美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431327744","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431327744?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:38","pubTimestamp":1714487934,"startTime":"0","endTime":"0","summary":"   * Protara Therapeutics Inc    将于5月2日公布截至2024年3月31日的财报() 预计该公司的季度收入将保持不变。*    * LSEG分析师对Protara Therapeutics Inc的平均预期是每股亏损92美分。* 华尔街对 Protara Therapeutics Inc 的 12 个月目标价中位数为 23.00 美元，高于其上次收盘价 3.10 美元。4月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431896586","title":"Protara Therapeutics, Inc.盘中异动 早盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431896586","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431896586?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:14","pubTimestamp":1714403662,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时14分，Protara Therapeutics, Inc.股票出现波动，股价急速上涨5.30%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Soleno Therapeutics, Inc.、Zura Bio Limited C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为944.22%、43.50%、20.79%，振幅较大的相关个股有Annovis Bio, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ginkgo Bioworks Holdings, Inc.，振幅分别为62.99%、33.33%、31.39%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为癌症和罕见疾病患者寻找和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292314227924fc97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292314227924fc97&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429922111","title":"Protara Therapeutics, Inc.盘中异动 早盘大幅上涨19.51%报3.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429922111","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429922111?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:32","pubTimestamp":1713792745,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时32分，Protara Therapeutics, Inc.股票出现波动，股价快速上涨19.51%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Moolec Science Sa、Adial Pharmaceuticals, Inc、亚狮康药业较为活跃，换手率分别为88.75%、44.49%、33.65%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech, Inc.，振幅分别为86.63%、20.71%、15.37%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222132258b464f1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222132258b464f1a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427737327","title":"Protara Therapeutics, Inc.盘中异动 急速跳水5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427737327","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427737327?lang=zh_cn&edition=full","pubTime":"2024-04-13 00:21","pubTimestamp":1712938867,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日00时21分，Protara Therapeutics, Inc.股票出现波动，股价大幅下挫5.50%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.24%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Q32 Bio Inc.涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3494.07%、1377.71%、86.78%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为93.97%、60.95%、58.59%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041300210779203f88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041300210779203f88&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426119836","title":"Protara Therapeutics, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426119836","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426119836?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:52","pubTimestamp":1712674329,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时52分，Protara Therapeutics, Inc.股票出现异动，股价快速跳水5.01%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。该信息摘要如下：HC Wainwright & Co.：维持Protara Therapeutics评级，由买入调整至买入评级, 目标价由23.00美元调整至23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409225210861e440d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409225210861e440d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425913257","title":"Protara Therapeutics, Inc.盘中异动 急速跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425913257","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425913257?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:49","pubTimestamp":1712584196,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时49分，Protara Therapeutics, Inc.股票出现异动，股价大幅下挫5.10%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。该信息摘要如下：HC Wainwright & Co.：维持Protara Therapeutics评级，由买入调整至买入评级, 目标价由23.00美元调整至23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408214956791f2cbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408214956791f2cbb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425563503","title":"Protara Therapeutics, Inc.股价飙升28.86% 市值涨1709.29万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425563503","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425563503?lang=zh_cn&edition=full","pubTime":"2024-04-05 21:31","pubTimestamp":1712323889,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日21时31分，Protara Therapeutics, Inc.股票出现异动，股价快速上涨28.86%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protara Therapeutics, Inc.涨幅较大，Candel Therapeutics, Inc.、Protara Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为34.81%、28.86%、10.76%，振幅较大的相关个股有Candel Therapeutics, Inc.、Protara Therapeutics, Inc.、康乃德生物，振幅分别为15.00%、13.18%、8.89%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052131308af434cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052131308af434cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421819171","title":"Protara Therapeutics, Inc.盘中异动 急速拉升8.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421819171","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421819171?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:30","pubTimestamp":1711114244,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时30分，Protara Therapeutics, Inc.股票出现波动，股价大幅上涨8.97%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Outlook Therapeutics, Inc.、Gt Biopharma, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Outlook Therapeutics, Inc.、Okyo Pharma Ltd Com Npv 、Nutriband Inc.较为活跃，换手率分别为27.27%、4.66%、3.32%，振幅较大的相关个股有Xtl生物制药、Elicio Therapeutics, Inc.、Seelos Therapeutics, Inc.，振幅分别为9.92%、7.88%、6.12%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222130447a4e8985&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222130447a4e8985&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421772193","title":"Protara Therapeutics, Inc.盘中异动 股价大涨6.25%报4.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421772193","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421772193?lang=zh_cn&edition=full","pubTime":"2024-03-21 02:53","pubTimestamp":1710960794,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日02时53分，Protara Therapeutics, Inc.股票出现波动，股价急速拉升6.25%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Xtl生物制药、Estrella Immunopharma Inc C/Wts 29/09/2028、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Xtl生物制药、Jaguar Health, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为212.77%、87.70%、46.72%，振幅较大的相关个股有Xtl生物制药、Nls Pharmaceutics Ltd.、Igc Pharma, Inc.，振幅分别为157.69%、83.33%、43.55%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321025314861dfd1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321025314861dfd1f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420471786","title":"Protara Therapeutics, Inc.盘中异动 早盘股价大涨5.71%报3.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420471786","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420471786?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:33","pubTimestamp":1710768812,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时33分，Protara Therapeutics, Inc.股票出现异动，股价急速拉升5.71%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc C/Wts 16/07/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Zyversa Therapeutics, Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为59.23%、12.07%、7.00%，振幅较大的相关个股有Elicio Therapeutics, Inc.、2Seventy Bio, Inc.、Molecular Templates, Inc.，振幅分别为12.93%、12.72%、12.55%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213332791b34f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213332791b34f0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417212738","title":"Protara Therapeutics, Inc.盘中异动 快速拉升5.88%报3.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417212738","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417212738?lang=zh_cn&edition=full","pubTime":"2024-03-07 01:20","pubTimestamp":1709745608,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日01时20分，Protara Therapeutics, Inc.股票出现异动，股价大幅上涨5.88%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，知临集团、Nkgen Biotech, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，知临集团、Nkgen Biotech, Inc.、Biomx Inc.较为活跃，换手率分别为1189.25%、325.48%、239.73%，振幅较大的相关个股有知临集团、Nkgen Biotech, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为1024.76%、314.39%、255.70%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070120097917ed28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070120097917ed28&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417414455","title":"Protara Therapeutics, Inc.盘中异动 早盘股价大跌6.30%报4.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417414455","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417414455?lang=zh_cn&edition=full","pubTime":"2024-03-05 22:39","pubTimestamp":1709649599,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日22时39分，Protara Therapeutics, Inc.股票出现波动，股价急速跳水6.30%。Protara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Apogee Therapeutics, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、CASI制药较为活跃，换手率分别为212.33%、97.50%、53.20%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Nrx Pharmaceuticals, Inc.、CASI制药，振幅分别为36.02%、22.08%、21.83%。Protara Therapeutics, Inc.公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030522395987e76199&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030522395987e76199&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416147753","title":"Protara Therapeutics Inc   预计每股亏损92美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2416147753","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416147753?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:06","pubTimestamp":1709564806,"startTime":"0","endTime":"0","summary":"   * Protara Therapeutics Inc    预计在3月6日公布截至2023年12月31日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Protara Therapeutics Inc的平均预期是每股亏损92美分。* 华尔街对 Protara Therapeutics Inc 的 12 个月目标价中位数为 26.00 美元，高于其上次收盘价 4.60 美元。3月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415374783","title":"Protara Therapeutics Inc盘中异动 快速跳水6.83%报4.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415374783","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415374783?lang=zh_cn&edition=full","pubTime":"2024-02-29 00:20","pubTimestamp":1709137202,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日00时20分，Protara Therapeutics Inc股票出现波动，股价急速跳水6.83%。Protara Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc涨幅较大，Adial Pharmaceuticals Inc、Vivani Medical Inc、Zyversa Therapeutics Inc较为活跃，换手率分别为4373.94%、194.08%、80.46%，振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为405.94%、219.84%、93.93%。Protara Therapeutics Inc公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402290020027a47c900&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402290020027a47c900&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414803577","title":"Protara Therapeutics Inc盘中异动 早盘大幅上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414803577","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414803577?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:36","pubTimestamp":1709044603,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时36分，Protara Therapeutics Inc股票出现异动，股价大幅拉升5.54%。Protara Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Janux Therapeutics Inc、Viking Therapeutics Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃，换手率分别为322.86%、90.92%、29.93%，振幅较大的相关个股有Janux Therapeutics Inc、Viking Therapeutics Inc、Fate Therapeutics，振幅分别为36.62%、25.26%、17.84%。Protara Therapeutics Inc公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722364387e739ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722364387e739ca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414838243","title":"Protara Therapeutics Inc盘中异动 大幅上涨5.58%报4.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414838243","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414838243?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:32","pubTimestamp":1708957921,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日22时32分，Protara Therapeutics Inc股票出现异动，股价快速拉升5.58%。Protara Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Zyversa Therapeutics Inc、Ocean Biomedical Inc C/Wts 14/02/2028 、Immunitybio Inc涨幅较大，Zyversa Therapeutics Inc、Lixte Biotechnology Holdings  Inc、Neubase Therapeutics Inc较为活跃，换手率分别为605.86%、57.13%、44.91%，振幅较大的相关个股有Sol Gel Technologies Ltd、Portage Biotech Inc、Ocean Biomedical Inc，振幅分别为22.60%、15.40%、15.29%。Protara Therapeutics Inc公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022622320187c2821e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022622320187c2821e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408639937","title":"Protara Therapeutics Inc盘中异动 急速拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408639937","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408639937?lang=zh_cn&edition=full","pubTime":"2024-02-01 22:31","pubTimestamp":1706797866,"startTime":"0","endTime":"0","summary":"北京时间2024年02月01日22时31分，Protara Therapeutics Inc股票出现波动，股价急速拉升5.88%。Protara Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Kiora Pharmaceuticals Inc、Elevai Labs Inc、Neurobo Pharmaceuticals Inc涨幅较大，Revelation Biosciences Inc、Kiora Pharmaceuticals Inc、Transcode Therapeutics Inc较为活跃，换手率分别为618.46%、203.54%、177.61%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Elevai Labs Inc、Gri Bio Inc，振幅分别为35.00%、18.83%、17.01%。Protara Therapeutics Inc公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402012231068161e470&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402012231068161e470&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407361714","title":"Protara Therapeutics Inc盘中异动 股价大涨5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407361714","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407361714?lang=zh_cn&edition=full","pubTime":"2024-01-31 00:04","pubTimestamp":1706630666,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日00时04分，Protara Therapeutics Inc股票出现波动，股价急速拉升5.91%。Protara Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Neximmune Inc、Pepgen Inc、Psyence Biomedical Ltd涨幅较大，Neximmune Inc、Panbela Therapeutics Inc、Iterum Therapeutics Plc较为活跃，换手率分别为764.85%、208.68%、163.13%，振幅较大的相关个股有Psyence Biomedical Ltd、Neximmune Inc、Pepgen Inc，振幅分别为800.00%、150.22%、61.72%。Protara Therapeutics Inc公司简介：Protara Therapeutics Inc 致力于为患有罕见疾病和特殊疾病的人确定和推进变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131000426861cefec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240131000426861cefec&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.protaratx.com","stockEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.2902},{"period":"3month","weight":0.0283},{"period":"6month","weight":1.1556},{"period":"1year","weight":-0.0459},{"period":"ytd","weight":0.5519}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Protara Therapeutics, Inc.最初于2006年3月24日在特拉华州注册成立。该公司是一家总部位于纽约市的临床阶段生物制药公司，致力于推进治疗癌症和罕见疾病的变革性疗法。该公司的产品组合包括两个利用TARA-002的开发项目，TARA-002是一种基于广泛免疫增强剂OK-432的研究性细胞疗法，该药物最初被日本厚生省授予上市许可，作为一种免疫增强型癌症治疗剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.108555},{"month":2,"riseRate":0.4,"avgChangeRate":0.022427},{"month":3,"riseRate":0.4,"avgChangeRate":-0.066369},{"month":4,"riseRate":0.4,"avgChangeRate":-0.095325},{"month":5,"riseRate":0.3,"avgChangeRate":0.074657},{"month":6,"riseRate":0.555556,"avgChangeRate":0.001838},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.068312},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.02728},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.060473},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.047023},{"month":11,"riseRate":0.8,"avgChangeRate":0.110888},{"month":12,"riseRate":0.5,"avgChangeRate":0.000367}],"exchange":"NASDAQ","name":"ArTara Therapeutics, Inc.","nameEN":"ArTara Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ArTara Therapeutics, Inc.(TARA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ArTara Therapeutics, Inc.(TARA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ArTara Therapeutics, Inc.,TARA,ArTara Therapeutics, Inc.股票,ArTara Therapeutics, Inc.股票老虎,ArTara Therapeutics, Inc.股票老虎国际,ArTara Therapeutics, Inc.行情,ArTara Therapeutics, Inc.股票行情,ArTara Therapeutics, Inc.股价,ArTara Therapeutics, Inc.股市,ArTara Therapeutics, Inc.股票价格,ArTara Therapeutics, Inc.股票交易,ArTara Therapeutics, Inc.股票购买,ArTara Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ArTara Therapeutics, Inc.(TARA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ArTara Therapeutics, Inc.(TARA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况